MAP2K6

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, MAP2K6 mutation is significantly associated with the RNA expression of many other genes, with 2,620 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible MAP2K6-associated genes across cancer lineages are PRAMEF11, RNU6-993P, and EDC3. Each is linked with MAP2K6 in more than 1 cancer types. Because this analysis shows association rather than direction, both MAP2K6-to-partner and partner-to-MAP2K6 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, PRAMEF11 grouped by MAP2K6-low versus MAP2K6-high in CESC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (MAP2K6→partner) and Y-score (partner→MAP2K6) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CESCPRAMEF11 →+0.021+5.969.009.00232
CESCRNU6-993P →+0.356+5.812<.001.00332
UCECEDC3 →+0.289+1.545.001.00532
UCECARID3B →+0.312+2.431.004.00132
UCECPCBP1-AS1 →+0.388+2.386<.001.00232
UCECLSM10 →+0.295+2.346.002<.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,620 associations by consensus.

PRAMEF11 by MAP2K6 expression — CESC

Box plot of PRAMEF11 in MAP2K6-low vs MAP2K6-high samples in CESC.

Explore this box plot interactively →

Exploration